The World Health Organization’s Vaccine Safety Advisory Committee will meet on Tuesday 16 March to address AstraZeneca’s vaccine-related issues. WHO Director-General Tedros Adan Ghebreyesus announced this at a briefing on Monday.
“The WHO Vaccine Safety Committee has reviewed the available evidence in contact with the European Medicines Agency and will meet tomorrow,” he said.
The head of WHO noted that the decision to suspend the use of the AstraZeneca vaccine is a routine practice. According to him, such a decision of the countries shows that the supervision system is working and there is an effective control.
Meanwhile, WHO Chief Scientist Sumiya Swaminathan said in an online briefing that there are no documented deaths yet associated with COVID-19 vaccines, Reuters reports.
As reported, a number of European countries temporarily suspended the use of the AstraZeneca vaccine due to possible side effects, in particular the formation of blood clots.